Abstract
On internalization, oligonucleotides (ODN) remain mostly sequestered in endocytic compartments. To increase their delivery into the cytosol and/or nucleus, which contain their targets, we attempted to guide them into compartments containing the KDEL receptor. Antisense ODN, phosphodiester protected at both ends, that are complementary to the AUG initiation site of gagHIV-1mRNA (odn) were linked to a peptide ending with the Lys-Asp-Glu-Leu (KDEL) motif in a carboxyl-terminal position (odn-p-KDEL) or with the Lys-Asp-Glu-Ala (odn-p-KDEA) as a control. The effect of odn substitution with a peptide was examined with regard to its accumulation, subcellular location, and activity in HepG2 cells. Although odn-p-KDEL was internalized 4-fold less than the corresponding peptide-free odn, it was 5-fold more efficient in inhibitinggagHIV-1 gene expression in HepG2 cells. The internalization of odn-p-KDEA was as low as that of odn-p-KDEL, but its biological activity was lower, close to that of the peptide-free odn. On endocytosis at 37°, both conjugates as well as the peptide-free odn were found in a neutral environment. However, the substitution of an odn with a KDEL motif altered its intracellular trafficking; most of the odn-p-KDEL was found in the endoplasmic reticulum and in the intermediate compartment as identified by colabeling with either anti-ERGIC-53 or anti-KDEL receptor antibodies. Conversely, odn-p-KDEA and peptide-free odn were localized in vesicular compartments not labeled with these antibodies. In addition, pulse-chase experiments showed that odn-p-KDEL and odn-p-KDEA had a lower efflux than peptide-free odn. Therefore, the large increase in efficiency was due to the KDEL motif.
Footnotes
-
Send reprint requests to: Annie-Claude Roche or Chantal Pichon, Glycobiologie CBM-CNRS, rue Charles Sadron, F-45071 Orléans Cedex 02, France. E-mail: roche{at}cnrs-orleans.fr
-
↵1 Current affiliation: Sératec, F-93800 Epinay sur Seine, France.
-
↵2 Current affiliation: Xenova Ltd., Slough SLI 4EF, UK.
-
↵3 C. Pichon, K. Arar, A. J. Stewart, M. Duc Dodon, L. Gazzolo, R. Mayer, M. Monsigny, and A.-C. Roche, unpublished observations.
-
This work was supported by grants from the Agence Nationale de Recherches sur le SIDA. K.A. received a fellowship from the Ministère de la Recherche et de la Technologie, and A.S. was supported by a postdoctoral fellowship from the Agence Nationale de Recherches sur le SIDA.
- Abbreviations:
- ODN
- oligonucleotide(s)
- odn
- phosphodiester oligonucleotide(s) (25-mer) complementary to the AUG initiation site of gagHIV-1
- ER
- endoplasmic reticulum
- PBS
- phosphate-buffered saline
- FBS
- fetal bovine serum
- DMEM
- Dulbecco’s modified Eagle’s medium
- BSA
- bovine serum albumin
- HIV
- human immunodeficiency virus
- IC
- intermediate compartment
- odn-p-KDEL
- oligonucleotide substituted with a peptide containing a KDEL motif
- odn-p-KDEA
- oligonucleotide substituted with a peptide containing a KDEA motif
- TGN
- trans-Golgi network
- F-odn
- fluoresceinylated odn
- Received September 9, 1996.
- Accepted November 7, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|